vTv Therapeutics Inc (VTVT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:vTv Therapeutics Inc (VTVT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7613
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
vTv Therapeutics Inc (vTv), formerly TransTech Inc, is a pharmaceutical company that discovers, develops and commercializes human therapeutics. The company offers a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, diabetes and metabolic disorders, inflammation and cancer. Its pipeline products include azeliragon, TTP399, TTP273, HPP593 and HPP737. vTv utilizes TTP translational technology to deliver clinical drug candidates against a wide range of biological targets including protein-protein interactions, receptor modulators, and enzyme inhibitors. The company collaborates with other pharmaceutical companies to discover and develop small molecule therapeutics for the treatment of major diseases. vTv is headquartered in High Point, North Carolina, the US.

vTv Therapeutics Inc (VTVT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
vTv Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
vTv Therapeutics to Raise USD10 Million in Venture Financing 11
Partnerships 12
vTv Therapeutics Enters into Agreement with Juvenile Diabetes Research Foundation 12
Licensing Agreements 13
Newsoara Biopharma Enters into licensing agreement with vTv Therapeutics 13
Reneo Pharma Enters into Licensing Agreement with vTv Therapeutics 14
Hangzhou Zhongmei Huadong Pharma to Enter into Licensing Agreement with vTv Therapeutics 15
vTv Therapeutics Enters into Licensing Agreement with Columbia University 16
Equity Offering 17
vTv Therapeutics Plans to Raise up to USD250 Million in Public Offering of Shares 17
vTv Therapeutics to Raise Funds through Private Placement of Shares 18
vTv Therapeutics Raises USD117.2 Million in IPO 19
vTv Therapeutics Inc – Key Competitors 20
vTv Therapeutics Inc – Key Employees 21
vTv Therapeutics Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 03, 2018: vTv Therapeutics announces second quarter 2018 results and update 23
May 15, 2018: vTv Therapeutics announces 2018 first quarter financial results 24
Feb 27, 2018: vTv Therapeutics Reports 2017 Fourth Quarter and Full Year Financial and Operational Results and Recent Highlights 25
Nov 01, 2017: vTv Therapeutics Reports Third Quarter 2017 Financial and Operational Results 27
Aug 02, 2017: vTv Therapeutics Reports Second Quarter 2017 Financial and Operational Results 29
May 03, 2017: vTv Therapeutics Reports First Quarter 2017 Financial and Operational Results 30
Feb 27, 2017: vTv Therapeutics Reports 2016 Fourth Quarter and Full Year Financial and Operational Results and Recent Highlights 31
Clinical Trials 33
Jun 12, 2018: vTv Therapeutics Announces Topline Results from Part B of Phase 3 STEADFAST Study 33
May 09, 2018: vTv Therapeutics Announces Company will Pre-specify New Subgroup with the FDA and Report Phase 3 Part B Results in June 34
Apr 09, 2018: vTv Therapeutics Announces Topline Results from the First STEADFAST Phase 3 Study Evaluating Azeliragon in People with Mild Alzheimer’s Disease 35
Nov 13, 2017: vTv to Host Key Opinion Leader Event to Discuss the Current State of Clinical Development in Alzheimers Disease 36
Oct 30, 2017: vTv Therapeutics to Present on Azeliragon at the 10th Clinical Trials on Alzheimer’s Disease (CTAD) 37
Aug 03, 2017: vTv Therapeutics Announces Issuance of US Patent Covering Methods of Treatment Using Azeliragon 38
Jul 13, 2017: vTv Therapeutics to Present Two Posters at the 2017 Alzheimer’s Association International Conference 39
Jun 01, 2017: vTv Therapeutics Completes Enrollment of Part B of Pivotal Phase III STEADFAST Trial Evaluating Azeliragon for the Treatment of Patients with Mild Alzheimer’s Disease 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
vTv Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
vTv Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
vTv Therapeutics to Raise USD10 Million in Venture Financing 11
vTv Therapeutics Enters into Agreement with Juvenile Diabetes Research Foundation 12
Newsoara Biopharma Enters into licensing agreement with vTv Therapeutics 13
Reneo Pharma Enters into Licensing Agreement with vTv Therapeutics 14
Hangzhou Zhongmei Huadong Pharma to Enter into Licensing Agreement with vTv Therapeutics 15
vTv Therapeutics Enters into Licensing Agreement with Columbia University 16
vTv Therapeutics Plans to Raise up to USD250 Million in Public Offering of Shares 17
vTv Therapeutics to Raise Funds through Private Placement of Shares 18
vTv Therapeutics Raises USD117.2 Million in IPO 19
vTv Therapeutics Inc, Key Competitors 20
vTv Therapeutics Inc, Key Employees 21
vTv Therapeutics Inc, Subsidiaries 22

List of Figures
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
vTv Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[vTv Therapeutics Inc (VTVT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fuller, Smith & Turner Plc:企業の戦略・SWOT・財務情報
    Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report Summary Fuller, Smith & Turner Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Chatham Lodging Trust:企業のM&A・事業提携・投資動向
    Chatham Lodging Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chatham Lodging Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Telefonaktiebolaget LM Ericsson:企業の戦略・SWOT・財務情報
    Telefonaktiebolaget LM Ericsson - Strategy, SWOT and Corporate Finance Report Summary Telefonaktiebolaget LM Ericsson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Penumbra Inc (PEN):医療機器:M&Aディール及び事業提携情報
    Summary Penumbra Inc (Penumbra) is a medical device company that designs, develops, manufactures and markets neuro devices and peripheral devices. The company’s neurovascular mechanical thrombectomy systems include revascularization device, reperfusion catheters, distal delivery catheters, neuro eva …
  • Telecom Argentina S.A.:戦略・SWOT・企業財務分析
    Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report Summary Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Skandinaviska Enskilda Banken AB:企業のM&A・事業提携・投資動向
    Skandinaviska Enskilda Banken AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Skandinaviska Enskilda Banken AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Sumitomo Bakelite Co Ltd (4203):企業の財務・戦略的SWOT分析
    Sumitomo Bakelite Co Ltd (4203) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Ingersoll-Rand plc:企業の戦略・SWOT・財務情報
    Ingersoll-Rand plc - Strategy, SWOT and Corporate Finance Report Summary Ingersoll-Rand plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Georgia Power Co:発電所・企業SWOT分析
    Georgia Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • HitGen LTD:企業のM&A・事業提携・投資動向
    HitGen LTD - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HitGen LTD Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Saint-Gobain Ltd:企業の戦略的SWOT分析
    Saint-Gobain Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Shibuya Kogyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Shibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • JCR Pharmaceuticals Co Ltd (4552):製薬・医療:M&Aディール及び事業提携情報
    Summary JCR Pharmaceuticals Co Ltd (JCR) manufactures, sells, buys, imports and exports pharmaceutical products. It provides biopharmaceuticals in the field of regenerative medicine for the treatment of rare diseases. The company offers pharmaceuticals to treat growth hormone deficiency, turner synd …
  • Asuragen Inc:医療機器:M&Aディール及び事業提携情報
    Summary Asuragen Inc (Asuragen) is an oncology molecular diagnostic company that provides laboratory medicine solutions. The company offers products such as amplidex, quantidex, and custom reagents. It provides custom and companion diagnostic services, which include commercialization, product approv …
  • American Municipal Power Inc:企業の戦略的SWOT分析
    American Municipal Power Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Neoen SAS:電力:M&Aディール及び事業提携情報
    Summary Neoen SAS (Neoen), a subsidiary of Direct Energie SA, is an independent producer of sustainable energy provider. The company generates power from solar, wind and biomass. It specializes in the development, finance, construction and operation of green power plants such as wind farms, solar fa …
  • Widex AS:企業の戦略的SWOT分析
    Widex AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • NBE-Therapeutics AG:製薬・医療:M&Aディール及び事業提携情報
    Summary NBE-Therapeutics AG (NBE-Therapeutics) is a biotechnology company that focuses on the development of antibody drug conjugates (ADC) to improve the treatment of cancer. ADCs act against cancer cells via tumor-specific antibodies and deliver powerful cellular toxins to such cancer cells. The c …
  • Infinity Turbine LLC:企業の戦略的SWOT分析
    Infinity Turbine LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Sojitz Corp (2768):石油・ガス:M&Aディール及び事業提携情報
    Summary Sojitz Corp (Sojitz) is a diversified general trading group. The group through its subsidiaries and affiliates holds interest in machinery; energy and metals; chemicals and functional materials; and consumer lifestyle businesses. It distributes automobiles and aircraft; develops power projec …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆